Profile: Roche Holding AG (ROG.VX)

ROG.VX on Virt-X Level 1

270.20CHF
17 Apr 2015
Change (% chg)

CHF-5.10 (-1.85%)
Prev Close
CHF275.30
Open
CHF275.80
Day's High
CHF276.40
Day's Low
CHF269.70
Volume
1,917,938
Avg. Vol
2,001,993
52-wk High
CHF295.80
52-wk Low
CHF238.80

Search Stocks
Roche Holding AG is a Switzerland-based pharmaceuticals and diagnostics company. It discovers, develops and provides diagnostic and therapeutic products and services from early detection and prevention of diseases to diagnosis, treatment and treatment monitoring. The Company has two divisions: Pharmaceuticals and Diagnostics. It operates worldwide containing the United States, Western Europe, Japan and Asia-Pacific, among others. Diagnostics include five areas: Applied Science, Diabetes Care, Molecular Diagnostics, Tissue Diagnosis and Professional Diagnostics. It operates in five geographical regions: Europe, Middle East and Africa (EMEA); North America; Asia-Pacific; Latin America, and Japan. In September 2014, it accepted for payment of all shares of InterMune Inc. through its wholly owned subsidiary Klee Acquisition Corporation. Additionally, it offers hardware and software solutions for genomic analysis.

Company Address

Roche Holding AG

Grenzacherstr. 124
BASEL     4058
P: +419.732354295

Company Web Links

Search Stocks